OS Therapies Files Prospectus Supplement
Ticker: OSTX · Form: 424B5 · Filed: 2026-04-02T17:00:33-04:00
Sentiment: neutral
Topics: prospectus-supplement, filing, securities
TL;DR
OS Therapies filed a prospectus supplement on 4/2/26. Check for offering details.
AI Summary
OS Therapies Inc. filed a 424B5 form on April 2, 2026, related to a prospectus supplement. The filing details are associated with CIK 0001795091 and accession number 0001213900-26-039456. The company's mailing and business address is 15825 Shady Grove Road, Suite 135, Rockville, MD 20850.
Why It Matters
This filing indicates a potential offering or update to existing securities, which could impact investors' decisions regarding OS Therapies Inc.
Risk Assessment
Risk Level: low — This filing is a standard prospectus supplement and does not inherently indicate increased risk for the company.
Key Numbers
- 464170 — Prospectus Supplement Size (Size of the primary document filed)
Key Players & Entities
- OS Therapies Inc (company) — Filer
- 0001795091 (company) — CIK
- 0001213900-26-039456 (company) — SEC Accession Number
- 2026-04-02 (date) — Filing Date
- 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 (address) — Mailing and Business Address
FAQ
What is the purpose of this 424B5 filing?
The filing is a prospectus supplement, indicating an update or offering related to the company's securities.
When was this filing accepted by the SEC?
The filing was accepted on April 2, 2026.
What is the CIK number for OS Therapies Inc?
The CIK number for OS Therapies Inc is 0001795091.
Where is OS Therapies Inc located?
The company's mailing and business address is 15825 Shady Grove Road, Suite 135, Rockville, MD 20850.
What is the accession number for this specific filing?
The SEC accession number for this filing is 0001213900-26-039456.
From the Filing
EDGAR Filing Documents for 0001213900-26-039456 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 424B5 - Prospectus [Rule 424(b)(5)]: SEC Accession No. 0001213900-26-039456 Filing Date 2026-04-02 Accepted 2026-04-02 17:00:33 Documents 4 Document Format Files Seq Description Document Type Size 1 PROSPECTUS SUPPLEMENT ea0283943-424b5_ostherapies.htm 424B5 464170 2 GRAPHIC ea028394301_img1.jpg GRAPHIC 5256 3 GRAPHIC ea028394301_img2.jpg GRAPHIC 142334 4 GRAPHIC ea028394301_img3.jpg GRAPHIC 15028 Complete submission text file 0001213900-26-039456.txt 689724 Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793 OS Therapies Inc (Filer) CIK : 0001795091 (see all company filings) EIN. : 825118368 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 424B5 | Act: 33 | File No.: 333-289443 | Film No.: 26835070 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)